(Q44952432)

7 December 2017

title

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study (English)

1 reference

7 December 2017

1 reference

Jonas JB

1

1 reference

7 December 2017

Degenring RF

2

1 reference

7 December 2017

Kreissig I

3

1 reference

7 December 2017

Friedemann T

4

1 reference

7 December 2017

Akkoyun I

5

1 reference

7 December 2017

publication date

1 February 2005

1 reference

7 December 2017

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

163-170

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701438

7 December 2017

exact match

0 references

cites work

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Concentration of intravitreally injected triamcinolone acetonide in aqueous humour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone for refractory pseudophakic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intraocular pressure after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone in recurrence of choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

Age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

The clearance of intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Intravitreal triamcinolone and elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701438

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701438

1 reference

7 December 2017

1 reference